Search Results - Beth Christian

  • Showing 1 - 10 results of 10
Refine Results
  1. 1

    A cancer disparities curriculum in a hematology/oncology fellowship program by Marium Husain, Muhammad Salman Faisal, Dionisia Quiroga, Audrey M Sigmund, Gregory Otterson, Alison Walker, Samilia Obeng-Gyasi, Beth Christian

    Published in BMC Medical Education (2023-10-01)
    Get full text
    Article


  2. 2

    Impact of circulating lymphoma cells at diagnosis on outcomes in patients with Waldenstrom macroglobulinemia by Ansel Nalin, Qiuhong Zhao, Timothy Voorhees, David Bond, Yazeed Sawalha, Walter Hanel, Audrey Sigmund, Kaitlin Annunzio, Lapo Alinari, Robert Baiocchi, Kami Maddocks, Dan Jones, Beth Christian, Narendranath Epperla

    Published in Frontiers in Oncology (2023-09-01)
    Get full text
    Article


  3. 3

    Impact of diagnosis to treatment interval on outcomes in patients with newly diagnosed marginal zone lymphoma - a US multisite study by Narendranath Epperla, Geoffrey Shouse, Natalie S. Grover, Pallawi Torka, Kaitlin Annunzio, Marcus Watkins, Andrea Anampa-Guzmán, Beth Christian, Colin Thomas, Stefan K. Barta, Praveen Ramakrishnan Geethakumari, Reem Karmali, Nancy L. Bartlett, Adam J. Olszewski

    Published in Experimental Hematology & Oncology (2025-05-01)
    Get full text
    Article


  4. 4

    Impact of circulating lymphoma cells at diagnosis on outcomes in patients with newly diagnosed de novo diffuse large B-cell lymphoma by Sayan Mullick Chowdhury, Subodh Bhatta, Timothy J. Voorhees, Kaitlin Annunzio, David A. Bond, Yazeed Sawalha, Audrey Sigmund, Walter Hanel, Lalit Sehgal, Lapo Alinari, Robert Baiocchi, Kami Maddocks, Beth Christian, Dan Jones, Narendranath Epperla

    Published in Journal of Hematology & Oncology (2025-01-01)
    Get full text
    Article


  5. 5

    Evaluation of Ki-67 expression and large cell content as prognostic markers in MZL: a multicenter cohort study by Natalie S. Grover, Kaitlin Annunzio, Marcus Watkins, Pallawi Torka, Reem Karmali, Andrea Anampa-Guzmán, Timothy S. Oh, Heather Reves, Montreh Tavakkoli, Emily Hansinger, Beth Christian, Colin Thomas, Stefan K. Barta, Praveen Ramakrishnan Geethakumari, Nancy L. Bartlett, Geoffrey Shouse, Adam J. Olszewski, Narendranath Epperla

    Published in Blood Cancer Journal (2024-10-01)
    Get full text
    Article


  6. 6

    Outcomes associated with allogeneic hematopoietic stem cell transplantation for relapsed and refractory Hodgkin lymphoma in the era of novel agents by Muhammad Salman Faisal, Walter Hanel, Timothy Voorhees, Rui Li, Ying Huang, Abdullah Khan, David Bond, Yazeed Sawalha, John Reneau, Lapo Alinari, Robert Baiocchi, Beth Christian, Kami Maddocks, Yvonne Efebera, Sam Penza, Ayman Saad, Jonathan Brammer, Marcos DeLima, Samantha Jaglowski, Narendranath Epperla

    Published in Cancer Medicine (2023-04-01)
    Get full text
    Article


  7. 7

    P1071: COMBINATION OF PD-1 INHIBITION WITH IMMUNOMODULATORY DRUG TREATMENT IN HODGKIN AND LARGE B-CELL LYMPHOMA: RESULTS FROM A PHASE I/II STUDY by David Bond, Vedat Yildiz, Lai Wei, John Reneau, Yazeed Sawalha, Beth Christian, Jonathan Brammer, Jean Koff, Narendranath Epperla, Aubree Dendorfer, Lily Yang, Baiocchi Robert, Timothy Voorhees, Audrey Sigmund, Walter Hanel, Polina Shindiapina, Nathan Denlinger, Sam Penza, Samantha Jaglowski, Evandro Bezerra, Lapo Alinari, Kristie Blum, Kami Maddocks

    Published in HemaSphere (2023-08-01)
    Get full text
    Article


  8. 8

    Cumulative incidence, risk factors, and management of atrial fibrillation in patients receiving ibrutinib by Tracy E. Wiczer, Lauren B. Levine, Jessica Brumbaugh, Jessica Coggins, Qiuhong Zhao, Amy S. Ruppert, Kerry Rogers, Anli McCoy, Luay Mousa, Avirup Guha, Nyla A. Heerema, Kami Maddocks, Beth Christian, Leslie A. Andritsos, Samantha Jaglowski, Steven Devine, Robert Baiocchi, Jennifer Woyach, Jeffrey Jones, Michael Grever, Kristie A. Blum, John C. Byrd, Farrukh T. Awan

    Published in Blood Advances (2017-09-01)
    Get full text
    Article


  9. 9

    Impact of early relapse within 24 months after first-line systemic therapy (POD24) on outcomes in patients with marginal zone lymphoma: A US multisite study by Narendranath Epperla, Rina Li Welkie, Pallawi Torka, Geoffrey Shouse, Reem Karmali, Lauren Shea, Andrea Anampa-Guzmán, Timothy S. Oh, Heather Reaves, Montreh Tavakkoli, Kathryn Lindsey, Irl Brian Greenwell, Emily Hansinger, Colin Thomas, Sayan Mullick Chowdhury, Kaitlin Annunzio, Beth Christian, Stefan K. Barta, Praveen Ramakrishnan Geethakumari, Nancy L. Bartlett, Alex F. Herrera, Natalie S. Grover, Adam J. Olszewski

    Published in Journal of Hematology & Oncology (2023-05-01)
    Get full text
    Article


  10. 10

    Second primary malignancies following CAR T-cell therapy in patients with hematologic malignancies by Elvira Umyarova, Charles Pei, William Pellegrino, Qiuhong Zhao, Nidhi Sharma, Don Benson, Francesca Cottini, Evandro Bezerra, Jonathan Brammer, Naresh Bumma, Hannah Choe, Nathan Denlinger, Srinivas Devarakonda, Abdullah Khan, Sam Penza, Ashley Rosko, Sumithira Vasu, Sarah Wall, Lapo Alinari, Robert Baiocchi, David A. Bond, Beth Christian, Walter Hanel, Kami Maddocks, John Reneau, Yazeed Sawalha, Alma Habib, Audrey Sigmund, Timothy J. Voorhees, Marcos de Lima, Narendranath Epperla

    Published in Journal of Hematology & Oncology (2025-03-01)
    Get full text
    Article


Search Tools: